ArticleCureus2025
Long Road to Identifying Peritoneal Mesothelioma: An Elusive Diagnosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peritoneal mesothelioma is a rare and aggressive malignancy that often presents with non-specific abdominal symptoms such as ascites, leading to delayed diagnosis and treatment. It poses significant diagnostic challenges, especially in the absence of classical risk factors like asbestos exposure. We report the case of a 60-year-old woman with a background of coeliac disease and no known asbestos exposure, who presented with progressive abdominal distension and ascites. Initial investigations, including imaging, paracentesis, cytology and liver biopsy, failed to reveal a definitive cause. Despite multiple evaluations and treating a presumptive diagnosis of sarcoidosis, her symptoms persisted. One year after the initial presentation, imaging revealed peritoneal nodularity and enhancement. Following biopsy and immunohistochemistry, a multidisciplinary team discussion led to the diagnosis of peritoneal mesothelioma. The patient was commenced on chemotherapy which showed clinical improvement. This case underscores the importance of maintaining a high index of suspicion for rare malignancies such as peritoneal mesothelioma in patients with recurrent unexplained ascites, even in the absence of classical risk factors. Early multidisciplinary involvement and persistence in diagnostic evaluation are essential for timely diagnosis and management, which may improve patient outcomes in complex presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.